39 filings
8-K
SPRY
ARS Pharmaceuticals Inc
21 Mar 24
ARS Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
4:06pm
8-K
SPRY
ARS Pharmaceuticals Inc
7 Mar 24
Results of Operations and Financial Condition
12:56pm
8-K
SPRY
ARS Pharmaceuticals Inc
9 Nov 23
ARS Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Updates
4:02pm
8-K
SPRY
ARS Pharmaceuticals Inc
25 Sep 23
Regulation FD Disclosure
4:17pm
8-K
SPRY
ARS Pharmaceuticals Inc
20 Sep 23
Other Events
6:05am
8-K
lt711nuue
10 Aug 23
ARS Reports Second Quarter 2023 Financial Results and Provides Business Updates
4:05pm
8-K
oei vnbpu
28 Jun 23
Submission of Matters to a Vote of Security Holders
4:32pm
8-K
z8ir3nd h00ilmmf6off
16 May 23
Regulation FD Disclosure
4:31pm
8-K
yxuvoozzkbphe7tux
15 May 23
ARS Pharmaceuticals Highlights Progress and Reports First Quarter 2023 Financial Results
9:03am
8-K
9xo6 p1xd81w
9 May 23
Regulation FD Disclosure
9:12am
8-K
tce1 809x8lnwb45
23 Mar 23
ARS Pharmaceuticals Highlights Progress and Reports Fourth Quarter and Full Year 2022 Financial Results
4:09pm
8-K
1trbh
13 Mar 23
Regulation FD Disclosure
9:26am
8-K
ksnaxuhd3qu3 jgp
22 Feb 23
Entry into a Material Definitive Agreement
4:11pm
8-K
5x0se7
14 Feb 23
Results of Operations and Financial Condition
6:12am
8-K/A
0n9f30s gl97rpzedxox
17 Jan 23
Report of Independent Registered Public Accounting Firm
5:06pm
8-K
epikkg
9 Dec 22
Departure of Directors or Certain Officers
5:02pm
8-K
3dqx5 cl33jbe5fmx
6 Dec 22
Regulation FD Disclosure
5:07pm
8-K
hcxlxe87n
8 Nov 22
ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
4:51pm
8-K
frou5
2 Nov 22
Other Events
6:07am
8-K
vmn6061oln9j9
27 Oct 22
Entry into a Material Definitive Agreement
4:06pm